FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

P T A Schellekens

Research Profile

Anatomy

Physiology

Procedures

Chemicals & Drugs

Living Beings

HIV-1

Disorders

Concepts & Ideas

Phenomena

HIV Seropositivity

Activities & Behaviors

Homosexuality

Co-author Network

Publications

TOP 3
Bob Bermond; Sugianto Surachno; Anja Lok; Ineke J M ten Berge; Barbara Plasmans; Cornelis Kox; Esther Schuller; P T A Schellekens; Ronald Hamel
Memory functions in prednisone-treated kidney transplant patients.
Frederike J Bemelman; Si-La Yong; Rudi Tissingh; P T A Schellekens; Ineke J M ten Berge
Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
Bruno G Loos; Marijke Th L Roos; P T A Schellekens; Ubele van der Velden; Frank Miedema
Lymphocyte numbers and function in relation to periodontitis and smoking.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of P T A Schellekens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Bob Bermond; Sugianto Surachno; Anja Lok; Ineke J M ten Berge; Barbara Plasmans; Cornelis Kox; Esther Schuller; P T A Schellekens; Ronald Hamel
Memory functions in prednisone-treated kidney transplant patients.
Clinical transplantation 2005;19(4):512-7.
2005: Frederike J Bemelman; Si-La Yong; Rudi Tissingh; P T A Schellekens; Ineke J M ten Berge
Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
Transplant international : official journal of the European Society for Organ Transplantation 2005;18(4):423-8.
2004: Bruno G Loos; Marijke Th L Roos; P T A Schellekens; Ubele van der Velden; Frank Miedema
Lymphocyte numbers and function in relation to periodontitis and smoking.
Journal of periodontology 2004;75(4):557-64.
2003: René T Meijer; Sugianto Surachno; Si-La Yong; Frederike J Bemelman; Sandrine Florquin; Ineke J M ten Berge; P T A Schellekens
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.
Clinical and experimental immunology 2003;133(3):485-92.
2002: Frederike J Bemelman; S Yong; K J Parlevliet; Sugianto Surachno; P T A Schellekens; R J M ten Berge
No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipients.
Transplantation proceedings 2002;34(8):3165-7.
2002: Rob J Rentenaar; Frank N J van Diepen; René T Meijer; Sugianto Surachno; Joep M Wilmink; P T A Schellekens; Steven T Pals; René A W van Lier; Ineke J M ten Berge
Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.
Kidney international 2002;62(1):319-28.
2002: René T Meijer; R P Koopmans; Ineke J M ten Berge; P T A Schellekens
Pharmacokinetics of murine anti-human CD3 antibodies in man are determined by the disappearance of target antigen.
The Journal of pharmacology and experimental therapeutics 2002;300(1):346-53.
2001: Rieneke van Praag; Jan M Prins; Marijke Th L Roos; P T A Schellekens; Ineke J M ten Berge; Si-La Yong; Hanneke Schuitemaker; A J Eerenberg; Suzanne Jurriaans; Frank de Wolf; C H Fox; Jaap Goudsmit; F Miedema; Joep M A Lange
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.
Journal of clinical immunology 2001;21(3):218-26.
2001: René T Meijer; I Keur; Sugianto Surachno; Ineke J M ten Berge; P T A Schellekens
OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation.
Transplantation proceedings 2001;33(3):2196-7.
2001: René T Meijer; Si-La Yong; Ineke J M ten Berge; René A W van Lier; P T A Schellekens
Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation.
Clinical and experimental immunology 2001;123(3):511-9.
2001: René T Meijer; Si-La Yong; Sugianto Surachno; Ineke J M ten Berge; P T A Schellekens
Treatment of acute kidney allograft rejection with the nonmitogenic CD3 mAb CLB T3/4.A (IgA-CD3): absence of a correlation of clinical responsiveness with inhibition of lymphocyte reactivity in vitro.
Transplantation proceedings 2001;33(1-2):1229-30.
2000: Marijke Th L Roos; René A W van Lier; Dörte Hamann; Gerlinde J Knol; I Verhoofstad; Debbie Van Baarle; Frank Miedema; P T A Schellekens
Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.
The Journal of infectious diseases 2000;182(2):451-8.
2000: Tsehaynesh Messele; Marijke Th L Roos; Dörte Hamann; M Koot; Arnaud Fontanet; Frank Miedema; P T A Schellekens; Tobias F Rinke de Wit
Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assay.
Clinical and diagnostic laboratory immunology 2000;7(4):687-92.
1999: Jan M Prins; Suzanne Jurriaans; Rieneke van Praag; H Blaak; Ronald P van Rij; P T A Schellekens; Ineke J M ten Berge; Si-La Yong; C H Fox; Marijke Th L Roos; Frank de Wolf; Jaap Goudsmit; Hanneke Schuitemaker; Joep M A Lange
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.
AIDS (London, England) 1999;13(17):2405-10.
1999: D N H Enomoto; Jan R Mekkes; Patrick Bossuyt; Si-La Yong; T A Out; R Hoekzema; Menno A de Rie; P T A Schellekens; Ineke J M ten Berge; Corianne De Borgie; Jan D Bos
Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis).
Journal of the American Academy of Dermatology 1999;41(6):915-22.
1999: Daan W Notermans; Nadine Pakker; Dörte Hamann; NA Foudraine; Robbert H Kauffmann; Pieter L Meenhorst; Jaap Goudsmit; Marijke Th L Roos; P T A Schellekens; Frank Miedema; Sven A Danner
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
The Journal of infectious diseases 1999;180(4):1050-6.
1999: JJ Maas; NA Foudraine; P T A Schellekens; M E Mensen; J Veenstra; Marijke Th L Roos; Remko van Leeuwen; Roel A Coutinho
Reliability of tuberculin purified derivative skin testing and delayed-type hypersensitivity skin test anergy in HIV-infected homosexual men, at risk of tuberculosis.
AIDS (London, England) 1999;13(13):1784-5.
1999: Rob J Rentenaar; Peter C Wever; Frank N J van Diepen; P T A Schellekens; Pauline M Wertheim; Ineke J M ten Berge
CD4dullCD8bright double-positive T-lymphocytes have a phenotype of granzyme Bpos CD8pos memory T-lymphocytes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(6):1430-4.
1999: Ineke J M ten Berge; K J Parlevliet; M H Raasveld; S Buysmann; Frederike J Bemelman; P T A Schellekens
Guidelines for the optimal use of muromonab CD3 in transplantation.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1999;11(4):277-84.
1999: Tsehaynesh Messele; M Abdulkadir; Arnaud Fontanet; Beyene Petros; Dörte Hamann; M Koot; Marijke Th L Roos; P T A Schellekens; Frank Miedema; Tobias F Rinke de Wit
Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts.
Clinical and experimental immunology 1999;115(3):443-50.
1999: Peter C Wever; LH Spaeny; H J J van der Vliet; Rob J Rentenaar; Angela M Wolbink; Janto Surachno; Pauline M Wertheim; P T A Schellekens; C Erik Hack; Ineke J M ten Berge
Expression of granzyme B during primary cytomegalovirus infection after renal transplantation.
The Journal of infectious diseases 1999;179(3):693-6.
1999: Nadine Pakker; E D Kroon; Marijke Th L Roos; Sigrid A Otto; D Hall; Ferdinand W N M Wit; Dörte Hamann; Marchina E Van Der Ende; Frans A Claessen; Robbert H Kauffmann; Peter P Koopmans; Frank P Kroon; C H ten Napel; Herman Sprenger; Hugo M Weigel; Julio S G Montaner; Joep M A Lange; Peter Reiss; P T A Schellekens; Frank Miedema
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
AIDS (London, England) 1999;13(2):203-12.
1998: Ineke J M ten Berge; Peter C Wever; Rob J Rentenaar; LH Spaeny; Janto Surachno; Pauline M Wertheim; P T A Schellekens; C Erik Hack
Selective expansion of a peripheral blood CD8+ memory T cell subset expressing both granzyme B and L-selectin during primary viral infection in renal allograft recipients.
Transplantation proceedings 1998;30(8):3975-7.
1998: Rob J Rentenaar; Peter C Wever; Frank N J van Diepen; Theo A Out; P T A Schellekens; Ineke J M ten Berge
Concomitant detection by flow cytometry of the intragranular antigen granzyme B and the intranuclear antigen Ki-67 in peripheral blood mononuclear cells from healthy individuals and patients with acute CMV infection after renal transplantation.
Transplantation proceedings 1998;30(8):3958-9.
1998: JJ Maas; Marijke Th L Roos; IP Keet; E A Mensen; Anneke Krol; J Veenstra; P T A Schellekens; Suzanne Jurriaans; Roel A Coutinho; Frank Miedema
In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type 1 infection is associated with T cell nonresponsiveness in vitro.
The Journal of infectious diseases 1998;178(4):1024-9.
1998: Marijke Th L Roos; Maria Prins; M Koot; Frank de Wolf; Margreet Bakker; Roel A Coutinho; Frank Miedema; P T A Schellekens
Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS.
AIDS (London, England) 1998;12(14):1745-51.
1998: Nadine Pakker; Daan W Notermans; Rob J De Boer; Marijke Th L Roos; Frank de Wolf; A Hill; J M Leonard; Sven A Danner; Frank Miedema; P T A Schellekens
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.
Nature medicine 1998;4(2):208-14.
1998: Jan M Prins; P T A Schellekens; P Reiss
Continued therapy with HIV-1 protease inhibitors, despite previous hypersensitivity reactions, through coadministration of prednisone.
Scandinavian journal of infectious diseases 1998;30(6):612-3.
1997: Nadine Pakker; Marijke Th L Roos; Remko van Leeuwen; Menno D De Jong; M Koot; Peter Reiss; Joep M A Lange; Frank Miedema; Sven A Danner; P T A Schellekens
Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(5):318-26.
1997: Frank de Wolf; Ingrid J B Spijkerman; P T A Schellekens; Miranda W Langendam; CL Kuiken; Margreet Bakker; M Roos; Roel A Coutinho; Frank Miedema; Jaap Goudsmit
AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
AIDS (London, England) 1997;11(15):1799-806.
1997: R J M ten Berge; P T A Schellekens
[Immunology in clinical practice. VI. Current immunosuppressive drugs].
Nederlands tijdschrift voor geneeskunde 1997;141(47):2289-92.
1997: S Buysmann; P T A Schellekens; W J Tax; Ineke J M ten Berge
Different CD3/T cell receptor monoclonal antibodies have distinct capacities to induce adhesion of T lymphocytes to endothelium.
The Journal of laboratory and clinical medicine 1997;130(1):91-101.
1997: D N H Enomoto; P T A Schellekens; Si-La Yong; Ineke J M ten Berge; Jan R Mekkes; Jan D Bos
Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: a possible mechanism of action of PUVA therapy.
Photochemistry and photobiology 1997;65(1):177-80.
1996: Marijke Th L Roos; Frank Miedema; A P Meinesz; N A De Leeuw; Nadine Pakker; Joep M A Lange; Roel A Coutinho; P T A Schellekens
Low T cell reactivity to combined CD3 plus CD28 stimulation is predictive for progression to AIDS: correlation with decreased CD28 expression.
Clinical and experimental immunology 1996;105(3):409-15.
1996: J Veenstra; Rieneke van Praag; Anneke Krol; Pauline M E Wertheim-van Dillen; Hugo M Weigel; P T A Schellekens; Joep M A Lange; Roel A Coutinho; J T M van der Meer
Complications of varicella zoster virus reactivation in HIV-infected homosexual men.
AIDS (London, England) 1996;10(4):393-9.
1996: S Buysmann; F J Bemelman; P T A Schellekens; Y van Kooyk; Carl Figdor; Ineke J M ten Berge
Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3.
Blood 1996;87(1):404-11.
1995: F J Bemelman; S Buysmann; Si-La Yong; Frank N J van Diepen; P T A Schellekens; R J ten Berge
Biphasic granulocytopenia after administration of the first dose of OKT3.
The Journal of laboratory and clinical medicine 1995;126(6):571-9.
1995: J Veenstra; Anneke Krol; Rieneke van Praag; P H J Frissen; P T A Schellekens; Joep M A Lange; Roel A Coutinho; J T M van der Meer
Herpes zoster, immunological deterioration and disease progression in HIV-1 infection.
AIDS (London, England) 1995;9(10):1153-8.
1995: Marijke Th L Roos; Frank Miedema; M Koot; M Tersmette; Wim Schaasberg; Roel A Coutinho; P T A Schellekens
T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects.
The Journal of infectious diseases 1995;171(3):531-6.
1995: S Buysmann; Frank N J van Diepen; Si-La Yong; Sugianto Surachno; P T A Schellekens; R J ten Berge
Mechanism of lymphocytopenia following administration of corticosteroids.
Transplantation proceedings 1995;27(1):871-2.
1995: K J Parlevliet; M E Chamuleau; Si-La Yong; M H Raasveld; Ineke J M ten Berge; P T A Schellekens
Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitro.
Clinical and experimental immunology 1995;99(2):155-9.
1995: K J Parlevliet; F J Bemelman; Si-La Yong; C Erik Hack; Janto Surachno; J M Wilmink; Ineke J M ten Berge; P T A Schellekens
Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients.
Transplant international : official journal of the European Society for Organ Transplantation 1995;8(2):141-6.
1995: P T A Schellekens; M Koot; Marijke Th L Roos; M Tersmette; Frank Miedema
Immunologic and virologic markers determining progression to AIDS.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10 Suppl 2():S62-6.
1994: Ineke J M ten Berge; K J Parlevliet; Si-La Yong; Janto Surachno; J M Wilmink; P T A Schellekens
Toxicity of IgA anti-CD3 isotype switch variant in vivo.
Transplantation proceedings 1994;26(6):3150.
1994: F J Bemelman; S Buysmann; Janto Surachno; J M Wilmink; P T A Schellekens; Ineke J M ten Berge
Pretreatment with divided doses of steroids strongly decreases side effects of OKT3.
Kidney international 1994;46(6):1674-9.
1994: F J Bemelman; S Buysmann; J M Wilmink; Sugianto Surachno; C Erik Hack; P T A Schellekens; R J ten Berge
Effects of divided doses of steroids on side effects, cytokines, and activation of complement and granulocytes, coagulation and fibrinolysis after OKT3.
Transplantation proceedings 1994;26(6):3096-7.
1994: Marijke Th L Roos; N A de Leeuw; Frans A Claessen; H G Huisman; Neeltje Kootstra; L Meyaard; P T A Schellekens; Hanneke Schuitemaker; Frank Miedema
Viro-immunological studies in acute HIV-1 infection.
AIDS (London, England) 1994;8(11):1533-8.
1994: K J Parlevliet; Ineke J M ten Berge; Si-La Yong; Janto Surachno; J M Wilmink; P T A Schellekens
In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants.
The Journal of clinical investigation 1994;93(6):2519-25.
1994: F J Bemelman; K J Parlevliet; P T A Schellekens; Sugianto Surachno; EA van Royen; R J ten Berge
Sequestration of labelled granulocytes in the lungs following administration of OKT3 is dose-dependent.
Transplant immunology 1994;2(1):47-51.
1994: K J Parlevliet; R J ten Berge; M H Raasveld; Janto Surachno; J M Wilmink; P T A Schellekens
Low-dose OKT3 induction therapy following renal transplantation: a controlled study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(6):698-703.
1993: M Koot; P T A Schellekens; J W Mulder; Joep M A Lange; Marijke Th L Roos; Roel A Coutinho; M Tersmette; Frank Miedema
Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine.
The Journal of infectious diseases 1993;168(3):733-6.
1993: M H Raasveld; F J Bemelman; P T A Schellekens; Frank N J van Diepen; A van Dongen; EA van Royen; C Erik Hack; Ineke J M ten Berge
Complement activation during OKT3 treatment: a possible explanation for respiratory side effects.
Kidney international 1993;43(5):1140-9.
1993: M Koot; IP Keet; A H Vos; R E de Goede; Marijke Th L Roos; Roel A Coutinho; Frank Miedema; P T A Schellekens; M Tersmette
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
Annals of internal medicine 1993;118(9):681-8.
1993: M H Raasveld; E Bloemena; J M Wilmink; Sugianto Surachno; P T A Schellekens; R J ten Berge
Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study.
Transplant international : official journal of the European Society for Organ Transplantation 1993;6(2):89-94.
1992: M E Chamuleau; Ineke J M ten Berge; P T A Schellekens; J M Wilmink; R Q Hintzen; René A W van Lier
Serum levels of soluble CD27 in renal transplant recipients.
Transplantation 1992;54(5):932-6.
1992: K J Parlevliet; P T A Schellekens
Monoclonal antibodies in renal transplantation: a review.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5(4):234-46.
1992: P T A Schellekens; M Tersmette; Marijke Th L Roos; R P Keet; Frank de Wolf; Roel A Coutinho; Frank Miedema
Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype.
AIDS (London, England) 1992;6(7):665-9.
1992: Marijke Th L Roos; Joep M A Lange; R E de Goede; Roel A Coutinho; P T A Schellekens; Frank Miedema; M Tersmette
Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1992;165(3):427-32.
1991: Rob A Gruters; F G Terpstra; R E De Goede; J W Mulder; Frank de Wolf; P T A Schellekens; René A W van Lier; M Tersmette; Frank Miedema
Immunological and virological markers in individuals progressing from seroconversion to AIDS.
AIDS (London, England) 1991;5(7):837-44.
1991: Rob A Gruters; F G Terpstra; Joep M A Lange; Marijke Th L Roos; T Harkema; J W Mulder; Frank de Wolf; P T A Schellekens; Frank Miedema
Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intake.
AIDS (London, England) 1991;5(1):43-7.
1990: E Bloemena; R P Koopmans; S Weinreich; Chris J van Boxtel; P T A Schellekens
Pharmacodynamic modeling of lymphocytopenia and whole blood lymphocyte cultures in prednisolone-treated individuals.
Clinical immunology and immunopathology 1990;57(3):374-86.
1990: K J Parleviet; M Jonker; R J ten Berge; R A van Lier; J M Wilmink; P F Strengers; Lucien A Aarden; P T A Schellekens
Anti-CD3 murine monoclonal isotype switch variants tested for toxicity and immunologic monitoring in four chimpanzees.
Transplantation 1990;50(5):889-92.
1990: Carel J M van Noesel; Rob A Gruters; F G Terpstra; P T A Schellekens; René A W van Lier; Frank Miedema
Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men.
The Journal of clinical investigation 1990;86(1):293-9.
1990: E Bloemena; S Weinreich; P T A Schellekens
The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo.
Clinical and experimental immunology 1990;80(3):460-6.
1990: P T A Schellekens; Marijke Th L Roos; Frank de Wolf; Joep M A Lange; Frank Miedema
Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.
Journal of clinical immunology 1990;10(2):121-7.
1990: Jan W Mulder; Frank de Wolf; Jaap Goudsmit; P A Cload; Roel A Coutinho; A P Fiddian; P T A Schellekens; J van der Noordaa; Joep M A Lange
Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
Antiviral research 1990;13(3):127-38.
1989: Frank de Wolf; Joep M A Lange; J T Houweling; Jan W Mulder; J Beemster; P T A Schellekens; Roel A Coutinho; J van der Noordaa; Jaap Goudsmit
Appearance of predictors of disease progression in relation to the development of AIDS.
AIDS (London, England) 1989;3(9):563-9.
1989: E Bloemena; Marijke Th L Roos; J L Van Heijst; J M Vossen; P T A Schellekens
Whole-blood lymphocyte cultures.
Journal of immunological methods 1989;122(2):161-7.
1989: A A van der Heyden; E Bloemena; T A Out; J M Wilmink; P T A Schellekens; Marinus H J van Oers
The influence of immunosuppressive treatment on immune responsiveness in vivo in kidney transplant recipients.
Transplantation 1989;48(1):44-7.
1989: M Tersmette; Joep M A Lange; R E de Goede; Frank de Wolf; J K Eeftink-Schattenkerk; P T A Schellekens; Roel A Coutinho; J G Huisman; Jaap Goudsmit; F Miedema
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.
Lancet 1989;1(8645):983-5.
1989: E Bloemena; R H Van Oers; S Weinreich; A P Stilma-Meinesz; P T A Schellekens; René A W van Lier
The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro.
European journal of immunology 1989;19(5):943-6.
1989: M Tersmette; Rob A Gruters; Frank de Wolf; R E de Goede; Joep M A Lange; P T A Schellekens; Jaap Goudsmit; H G Huisman; Frank Miedema
Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
Journal of virology 1989;63(5):2118-25.
1989: F G Terpstra; B J Al; Marijke Th L Roos; Frank de Wolf; Jaap Goudsmit; P T A Schellekens; Frank Miedema
Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection.
European journal of immunology 1989;19(4):667-73.
1989: E Bloemena; René A W van Lier; Marinus H J van Oers; S Weinreich; A P Stilma-Meinesz; P T A Schellekens
The effects of prednisolone and cyclosporin A on monocyte-dependent and -independent human T-cell proliferation in vitro.
Transplantation proceedings 1989;21(1 Pt 1):861-5.
1988: Frank de Wolf; M Roos; Joep M A Lange; J T Houweling; Roel A Coutinho; J van der Noordaa; P T A Schellekens; Jaap Goudsmit
Decline in CD4+ cell numbers reflects increase in HIV-1 replication.
AIDS research and human retroviruses 1988;4(6):433-40.
1988: Frank de Wolf; Joep M A Lange; J T Houweling; Roel A Coutinho; P T A Schellekens; J van der Noordaa; Jaap Goudsmit
Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men.
The Journal of infectious diseases 1988;158(3):615-22.
1988: E Bloemena; Marinus H J van Oers; S Weinreich; S L Yong; P T A Schellekens
Prednisolone and cyclosporin A exert differential inhibitory effects on T-cell proliferation in vitro.
Clinical immunology and immunopathology 1988;48(3):380-91.
1988: A A van der Heyden; Marinus H J van Oers; P Cornelissen; S L Yong; J M Wilmink; P T A Schellekens
The influence of cyclosporine A treatment on immune responsiveness in vitro and in vivo in kidney transplant recipients.
Transplantation proceedings 1988;20(2 Suppl 2):190-5.
1988: E Bloemena; Marinus H J van Oers; S Weinreich; S L Yong; P T A Schellekens
Cyclosporine A does not prevent expression of biologically active IL 2 receptors in vitro.
Transplantation proceedings 1988;20(2 Suppl 2):131-5.
1988: Frank de Wolf; Joep M A Lange; Jaap Goudsmit; P Cload; Jan de Gans; P T A Schellekens; Roel A Coutinho; A P Fiddian; J van der Noordaa
Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects.
Lancet 1988;1(8582):373-6.
1988: E Braakman; P Treep-van Leeuwen; R J ten Berge; P T A Schellekens; C J Lucas
Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisolone.
Clinical and experimental immunology 1988;71(2):302-7.
1988: E Bloemena; Marinus H J van Oers; S Weinreich; P T A Schellekens
Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2.
Clinical and experimental immunology 1988;71(2):308-13.
1988: J K Eeftinck Schattenkerk; Sven A Danner; Joep M A Lange; D A Paul; C J van Boxtel; F Miedema; P T A Schellekens; Jaap Goudsmit
Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control study.
Archives of internal medicine 1988;148(1):209-11.
1987: K Korver; Elisabeth Boeschoten; Raymond T Krediet; G van Steenis; P T A Schellekens
Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: shift in some immunodeficiency states.
Clinical and experimental immunology 1987;70(2):328-35.
1987: B Oosterhuis; I J ten Berge; P T A Schellekens; C J van Boxtel
Concentration-dependent effects of prednisolone on lymphocyte subsets and mixed lymphocyte culture in humans.
The Journal of pharmacology and experimental therapeutics 1987;243(2):716-22.
1987: Frank de Wolf; Jaap Goudsmit; D A Paul; Joep M A Lange; C Hooijkaas; P T A Schellekens; Roel A Coutinho; J van der Noordaa
Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.
British medical journal (Clinical research ed.) 1987;295(6598):569-72.
1986: B Oosterhuis; I J ten Berge; P T A Schellekens; R P Koopmans; Chris J van Boxtel
Prednisolone concentration-effect relations in humans and the influence of plasma hydrocortisone.
The Journal of pharmacology and experimental therapeutics 1986;239(3):919-26.
1985: Ineke J M ten Berge; J M Wilmink; C J Meyer; Janto Surachno; K H ten Veen; T G Balk; P T A Schellekens
Clinical and immunological follow-up of patients with severe renal disease in Wegener's granulomatosis.
American journal of nephrology 1985;5(1):21-9.
1984: H C Rümke; F G Terpstra; Marijke Th L Roos; J M Vossen; L J Dooren; P T A Schellekens; W P Zeijlemaker
Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production.
Clinical and experimental immunology 1984;57(2):467-78.
1984: R J ten Berge; H P Sauerwein; Si-La Yong; P T A Schellekens
Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes.
Clinical immunology and immunopathology 1984;30(1):91-103.
1983: J Goudsmit; Pauline M E Wertheim-van Dillen; P T A Schellekens; R A Coutinho; S A Danner; J van der Noordaa
Acquired immune deficiency syndrome, altered T cell subset ratios, and cytomegalovirus infections among male homosexuals in The Netherlands.
Antibiotics and chemotherapy 1983;32():138-46.
1982: R J ten Berge; P T A Schellekens; Sugianto Surachno; T H The; J H ten Veen; J M Wilmink
A longitudinal study on the effects of azathioprine and high doses of prednisone on the immune system of kidney-transplant recipients.
Clinical immunology and immunopathology 1982;24(1):33-46.
1981: R J ten Berge; P T A Schellekens; Sugianto Surachno; T H The; J H ten Veen; J M Wilmink
The influence of therapy with azathioprine and prednisone on the immune system of kidney transplant recipients.
Clinical immunology and immunopathology 1981;21(1):20-32.